ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) Announces Positive Pre-clinical Data on Darinaparsin in Leukemia Publication
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of…